In the article ''Platelet-to-lymphocyte ratio predicts contrastinduced nephropathy in patients with non-ST-segment elevation acute coronary syndrome'' by Kocas et al, 1 the authors reported that platelet-to-lymphocyte ratio (PLR) was found to be an independent predictor of contrast-induced nephropathy (CIN) after coronary angiography in patients with non-ST segment elevation acute coronary syndrome.
The study of Kocas et al 1 includes patients with near-normal renal functions. However, there are no data about incidence of patients treated with chronic renin-angiotensin-aldosterone system (RAAS) blockers and periprocedural renoprotective treatments. Chronic usage of RAAS blockers increases the risk of CIN in patients with near normal renal functions who underwent coronary procedures. 2 Additionally, periprocedural hydration with sodium bicarbonate plays a protective role against CIN while performing coronary procedures. 3 The authors 1 reported that patients in CIN group had higher prevalence of diabetes mellitus, hypertension, and chronic kidney disease. Therefore, higher incidence of treatment with chronic RAAS blockers and less treatment with renoprotective regimens may play a significant role for higher incidence of CIN in the Kocas et al study. 1 Higher PLR levels may be an indicator for the development of CIN. To define its exact role, we should be sure that both patient groups have similar incidence of chronic RAAS blockers usage and treatment with periprocedural renoprotective regimens. It would be worth assessing if renal function indices were diferent in patients taking RAAS blockers before and after coronary angiography even if they did not develop CIN. 4, 5 
